Boeing Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Boeing Co reported revenue of $89.5B (+34.5% year on year) and net income of $2.2B (+118.9% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Total revenues | $89.5B | $66.5B | $77.8B | $66.6B |
| Cost of goods and services sold | ($85.2B) | ($68.5B) | ($70.1B) | ($63.1B) |
| Total costs and expenses | ($85.2B) | ($68.5B) | ($70.1B) | ($63.1B) |
| Gross profit | $4.3B | ($2.0B) | $7.7B | $3.5B |
| Income from operating investments, net | $25.0M | $71.0M | $46.0M | ($16.0M) |
| General and administrative expense | ($6.1B) | ($5.0B) | ($5.2B) | ($4.2B) |
| Research and development expense, net | ($3.6B) | ($3.8B) | ($3.4B) | ($2.9B) |
| Gain on dispositions, net | ($9.7B) | $46.0M | $2.0M | $6.0M |
| Earnings/(loss) from operations | $4.3B | ($10.7B) | ($773.0M) | ($3.5B) |
| Other income, net | $1.1B | $1.2B | $1.2B | $1.1B |
| Interest and debt expense | ($2.8B) | ($2.7B) | ($2.5B) | ($2.5B) |
| Earnings/(loss) before income taxes | $2.6B | ($12.2B) | ($2.0B) | ($5.0B) |
| Income tax (expense)/benefit | ($397.0M) | $381.0M | ($237.0M) | ($31.0M) |
| Net earnings/(loss) | $2.2B | ($11.8B) | ($2.2B) | ($5.1B) |
| Less: Net earnings/(loss) attributable to noncontrolling interest | $3.0M | ($12.0M) | ($20.0M) | ($118.0M) |
| Net earnings/(loss) attributable to Boeing shareholders | $2.2B | ($11.8B) | ($2.2B) | ($4.9B) |
| Less: Mandatory convertible preferred stock dividends accumulated during the period | $345.0M | $58.0M | — | — |
| Net earnings/(loss) attributable to Boeing common shareholders | $1.9B | ($11.9B) | — | — |
| Basic earnings/(loss) per share (in dollars per share) | $2.49 | -$18.36 | -$3.67 | -$8.30 |
| Diluted earnings/(loss) per share (in dollars per share) | $2.48 | -$18.36 | -$3.67 | -$8.30 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Total revenues | $24.6B | $22.2B | $23.3B | $22.7B |
| Cost of products and services | ($22.1B) | ($19.7B) | ($25.6B) | ($20.3B) |
| Total costs and expenses | ($22.1B) | ($19.7B) | ($25.6B) | ($20.3B) |
| Gross profit | $2.4B | $2.5B | ($2.4B) | $2.4B |
| Income from operating investments, net | $24.0M | ($10.0M) | $14.0M | $25.0M |
| General and administrative expense | ($1.4B) | ($1.2B) | ($1.5B) | ($1.8B) |
| Research and development expense, net | ($921.0M) | ($903.0M) | ($897.0M) | ($910.0M) |
| Gain on dispositions, net | $67.0M | $12.0M | ($1.0M) | $67.0M |
| Earnings/(loss) from operations | $156.0M | $448.0M | ($4.8B) | ($176.0M) |
| Other income, net | $79.0M | $194.0M | $276.0M | $325.0M |
| Interest and debt expense | ($600.0M) | ($616.0M) | ($694.0M) | ($710.0M) |
| Loss before income taxes | ($365.0M) | $26.0M | ($5.2B) | ($561.0M) |
| Income tax expense | ($63.0M) | ($33.0M) | ($140.0M) | ($51.0M) |
| Net loss | ($428.0M) | ($7.0M) | ($5.3B) | ($612.0M) |
| Less: Net earnings/(loss) attributable to noncontrolling interest | $16.0M | ($3.0M) | ($2.0M) | ($1.0M) |
| Net loss attributable to Boeing shareholders | ($444.0M) | ($4.0M) | ($5.3B) | ($611.0M) |
| Less: Mandatory convertible preferred stock dividends accumulated during the period | $86.0M | $86.0M | $87.0M | $86.0M |
| Net loss attributable to Boeing common shareholders | ($530.0M) | ($90.0M) | ($5.4B) | ($697.0M) |
| Basic loss per share (in dollars per share) | -$0.67 | -$0.11 | -$7.14 | -$0.92 |
| Diluted loss per share (in dollars per share) | -$0.67 | -$0.11 | -$7.14 | -$0.92 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $10.9B | $13.8B | $12.7B | $14.6B |
| Short-term and other investments | $18.5B | $12.5B | $3.3B | $2.6B |
| Accounts receivable, net | $2.9B | $2.6B | $2.6B | $2.5B |
| Unbilled receivables, net | $9.2B | $8.4B | $8.3B | $8.6B |
| Inventories | $84.7B | $87.5B | $79.7B | $78.2B |
| Other current assets, net | $2.3B | $3.0B | $2.5B | $2.8B |
| Total current assets | $128.5B | $128.0B | $109.3B | $109.5B |
| Financing receivables and operating lease equipment, net | $241.0M | $314.0M | $860.0M | — |
| Property, plant and equipment, net | $15.4B | $11.4B | $10.7B | $10.6B |
| Goodwill | $17.3B | $8.1B | $8.1B | $8.1B |
| Acquired intangible assets, net | $1.6B | $2.0B | $2.1B | $2.3B |
| Deferred income taxes | $107.0M | $185.0M | $59.0M | $63.0M |
| Investments | $1.0B | $999.0M | $1.0B | $983.0M |
| Other assets, net of accumulated amortization of $1,014 and $1,085 | $4.2B | $5.4B | $4.9B | $4.2B |
| Total assets | $168.2B | $156.4B | $137.0B | $137.1B |
| Accounts payable | $13.1B | $11.4B | $12.0B | $10.2B |
| Accrued liabilities | $27.1B | $24.1B | $22.3B | $21.6B |
| Advances and progress billings | $59.4B | $60.3B | $56.3B | $53.1B |
| Short-term debt and current portion of long-term debt | $8.5B | $1.3B | $5.2B | $5.2B |
| Total current liabilities | $108.1B | $97.1B | $95.8B | $90.1B |
| Deferred income taxes | $216.0M | $122.0M | $229.0M | $230.0M |
| Accrued retiree health care | $2.1B | $2.2B | $2.2B | $2.5B |
| Accrued pension plan liability, net | $4.3B | $6.0B | $6.5B | $6.1B |
| Other long-term liabilities | $2.4B | $2.3B | $2.3B | $2.2B |
| Long-term debt | $45.6B | $52.6B | $47.1B | $51.8B |
| Total liabilities | $162.8B | $160.3B | $154.2B | $152.9B |
| Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750 | 6.0M | 6.0M | — | — |
| Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued | 5.1B | 5.1B | 5.1B | 5.1B |
| Additional paid-in capital | $21.4B | $19.0B | $10.3B | $9.9B |
| Treasury stock, at cost | ($28.0B) | ($32.4B) | ($49.5B) | ($50.8B) |
| Retained earnings | $17.3B | $15.4B | $27.3B | $29.5B |
| Accumulated other comprehensive loss | ($10.3B) | ($10.9B) | ($10.3B) | ($9.6B) |
| Total shareholders' equity/(deficit) | $5.5B | ($3.9B) | ($17.2B) | ($15.9B) |
| Noncontrolling interests | $3.0M | ($6.0M) | $5.0M | $35.0M |
| Total equity | $5.5B | ($3.9B) | ($17.2B) | ($15.8B) |
| Total liabilities and equity | $168.2B | $156.4B | $137.0B | $137.1B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $7.2B | $9.4B | $6.2B | $7.1B |
| Short-term and other investments | $12.8B | $11.5B | $16.8B | $15.9B |
| Accounts receivable, net | $3.5B | $3.5B | $3.3B | $3.2B |
| Unbilled receivables, net | $9.7B | $9.8B | $9.0B | $9.3B |
| Inventories | $88.4B | $87.2B | $82.4B | $87.9B |
| Other current assets, net | $3.0B | $2.7B | $2.9B | $2.6B |
| Total current assets | $124.6B | $124.1B | $122.1B | $127.3B |
| Financing receivables and operating lease equipment, net | $365.0M | $389.0M | $245.0M | $318.0M |
| Property, plant and equipment, net of accumulated depreciation of $24,318 and $23,613 | $16.3B | $15.8B | $12.1B | $11.7B |
| Goodwill | $17.6B | $17.6B | $7.3B | $7.3B |
| Acquired intangible assets, net | $1.5B | $1.5B | $1.5B | $1.5B |
| Deferred income taxes | $152.0M | $136.0M | $44.0M | $136.0M |
| Investments | $1.1B | $1.0B | $1.1B | $1.0B |
| Other assets, net of accumulated amortization of $1,138 and $1,014 | $4.2B | $4.2B | $5.7B | $5.8B |
| Total assets | $165.9B | $164.8B | $150.0B | $155.1B |
| Accounts payable | $14.3B | $13.7B | $11.7B | $11.2B |
| Accrued liabilities | $26.6B | $26.4B | $24.4B | $23.5B |
| Advances and progress billings | $64.1B | $62.6B | $58.0B | $59.4B |
| Short-term debt and current portion of long-term debt | $4.6B | $2.9B | $8.7B | $8.7B |
| Total current liabilities | $109.6B | $105.5B | $103.3B | $103.4B |
| Deferred income taxes | $260.0M | $237.0M | $191.0M | $193.0M |
| Accrued retiree health care | $2.0B | $2.1B | $2.1B | $2.1B |
| Accrued pension plan liability, net | $4.1B | $4.2B | $5.7B | $5.8B |
| Other long-term liabilities | $2.5B | $2.4B | $2.4B | $2.3B |
| Long-term debt | $41.3B | $44.4B | $44.6B | $44.6B |
| Total liabilities | $159.8B | $158.8B | $158.3B | $158.4B |
| Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750 | 6.0M | 6.0M | 6.0M | 6.0M |
| Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued | 5.1B | 5.1B | 5.1B | 5.1B |
| Additional paid-in capital | $21.9B | $21.7B | $19.2B | $19.2B |
| Treasury stock, at cost – 222,468,625 and 227,562,887 shares | -27.4B | -27.6B | -31.1B | -31.6B |
| Retained earnings | $16.6B | $17.2B | $9.1B | $14.5B |
| Accumulated other comprehensive loss | ($10.1B) | ($10.3B) | ($10.5B) | ($10.5B) |
| Total shareholders' equity | $6.1B | $6.0B | ($8.3B) | ($3.3B) |
| Noncontrolling interests | $15.0M | — | ($3.0M) | ($1.0M) |
| Total equity | $6.1B | $6.0B | ($8.3B) | ($3.3B) |
| Total liabilities and equity | $165.9B | $164.8B | $150.0B | $155.1B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net earnings/(loss) | $2.2B | ($11.8B) | ($2.2B) | ($5.1B) |
| Share-based plans expense | $426.0M | $407.0M | $690.0M | $725.0M |
| Treasury shares issued for 401(k) contribution | 1.5B | 1.6B | 1.5B | 1.2B |
| Depreciation and amortization | $2.0B | $1.8B | $1.9B | $2.0B |
| Investment/asset impairment charges, net | $45.0M | $112.0M | $46.0M | $112.0M |
| Gain on dispositions, net | ($9.7B) | ($46.0M) | ($2.0M) | ($6.0M) |
| 777X and 767 reach-forward losses | $5.3B | $4.1B | — | — |
| Other charges and credits, net | $264.0M | $528.0M | $3.0M | $364.0M |
| Accounts receivable | ($95.0M) | ($37.0M) | ($128.0M) | $142.0M |
| Unbilled receivables | ($677.0M) | ($60.0M) | $321.0M | $6.0M |
| Advances and progress billings | ($723.0M) | $4.1B | $3.4B | $108.0M |
| Inventories | ($1.5B) | ($12.4B) | ($1.7B) | $420.0M |
| Other current assets | $155.0M | ($16.0M) | $389.0M | ($591.0M) |
| Accounts payable | $724.0M | ($793.0M) | $1.7B | $838.0M |
| Accrued liabilities | $1.3B | $1.6B | $779.0M | $3.0B |
| Income taxes receivable, payable and deferred | $115.0M | ($567.0M) | $44.0M | $1.3B |
| Other long-term liabilities | ($346.0M) | ($329.0M) | ($313.0M) | ($158.0M) |
| Pension and other postretirement plans | ($593.0M) | ($959.0M) | ($1.0B) | ($1.4B) |
| Financing receivables and operating lease equipment, net | $274.0M | $512.0M | $571.0M | — |
| Other | $324.0M | $202.0M | $119.0M | $307.0M |
| Net cash provided/(used) by operating activities | $1.1B | ($12.1B) | $6.0B | $3.5B |
| Payments to acquire property, plant and equipment | ($2.9B) | ($2.2B) | ($1.5B) | ($1.2B) |
| Proceeds from disposals of property, plant and equipment | $82.0M | $49.0M | $27.0M | $35.0M |
| Acquisitions, net of cash acquired | ($1.2B) | ($50.0M) | ($70.0M) | — |
| Proceeds from dispositions | $10.6B | $124.0M | — | — |
| Contributions to investments | ($51.9B) | ($13.9B) | ($16.4B) | ($5.1B) |
| Proceeds from investments | $46.6B | $4.7B | $15.7B | $10.6B |
| Supplier notes receivable | ($662.0M) | ($694.0M) | — | — |
| Repayments on supplier notes receivable | $2.0M | $40.0M | — | — |
| Purchase of distribution rights | ($9.0M) | ($88.0M) | — | — |
| Other | $1.0M | ($11.0M) | ($158.0M) | ($11.0M) |
| Net cash provided/(used) by investing activities | $499.0M | ($12.0B) | ($2.4B) | $4.4B |
| New borrowings | $165.0M | $10.2B | $75.0M | $34.0M |
| Debt repayments | ($3.6B) | ($8.7B) | ($5.2B) | ($1.3B) |
| Employee taxes on certain share-based payment arrangements | ($34.0M) | ($83.0M) | ($408.0M) | ($40.0M) |
| Dividends paid on Mandatory convertible preferred stock | ($331.0M) | — | — | — |
| Other | $58.0M | ($53.0M) | $17.0M | — |
| Net cash (used)/provided by financing activities | ($3.8B) | $25.2B | ($5.5B) | ($1.3B) |
| Effect of exchange rate changes on cash and cash equivalents | $40.0M | ($47.0M) | $30.0M | ($73.0M) |
| Net (decrease)/increase in cash & cash equivalents, including restricted | ($2.2B) | $1.1B | ($1.9B) | $6.5B |
| Cash & cash equivalents, including restricted, at beginning of year | $13.8B | $12.7B | $14.6B | $8.1B |
| Cash & cash equivalents, including restricted, at end of year | $11.7B | $13.8B | $12.7B | $14.6B |
| Less restricted cash & cash equivalents, included in Investments | $742.0M | $21.0M | $22.0M | $33.0M |
| Cash and cash equivalents at end of year | $10.9B | $13.8B | $12.7B | $14.6B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net (loss)/earnings | ($435.0M) | ($7.0M) | ($6.0B) | ($643.0M) |
| Share-based plans expense | $264.0M | $161.0M | $343.0M | $254.0M |
| Treasury shares issued for 401(k) contributions | 855.0M | 466.0M | 1.2B | 793.0M |
| Depreciation and amortization | $1.2B | $573.0M | $1.4B | $926.0M |
| Investment/asset impairment charges, net | $18.0M | $9.0M | $32.0M | $30.0M |
| Gain on dispositions, net | ($79.0M) | ($12.0M) | ($63.0M) | ($64.0M) |
| Other charges and credits, net | $149.0M | $45.0M | $217.0M | $162.0M |
| Accounts receivable | ($553.0M) | ($509.0M) | ($836.0M) | ($683.0M) |
| Unbilled receivables | ($504.0M) | ($635.0M) | ($679.0M) | ($908.0M) |
| Advances and progress billings | $4.7B | $3.2B | ($2.1B) | ($616.0M) |
| Inventories | ($3.9B) | ($2.6B) | ($116.0M) | ($374.0M) |
| Other current assets | ($642.0M) | ($418.0M) | $227.0M | $265.0M |
| Accounts payable | $1.4B | $1.1B | $539.0M | ($46.0M) |
| Accrued liabilities | ($1.1B) | ($1.3B) | $574.0M | ($248.0M) |
| Income taxes receivable, payable and deferred | ($20.0M) | ($16.0M) | $93.0M | ($3.0M) |
| Other long-term liabilities | ($92.0M) | ($49.0M) | ($294.0M) | ($212.0M) |
| Pension and other postretirement plans | ($55.0M) | ($22.0M) | ($436.0M) | ($292.0M) |
| Financing receivables and operating lease equipment, net | ($137.0M) | ($156.0M) | $274.0M | $185.0M |
| Other | $135.0M | $31.0M | $176.0M | $85.0M |
| Net cash provided/(used) by operating activities | $1.2B | ($179.0M) | ($266.0M) | ($1.4B) |
| Payments to acquire property, plant and equipment | ($2.0B) | ($1.3B) | ($2.0B) | ($1.1B) |
| Proceeds from disposals of property, plant and equipment | $3.0M | $2.0M | $5.0M | $4.0M |
| Contributions to investments | ($19.4B) | ($9.3B) | ($36.3B) | ($21.6B) |
| Proceeds from investments | $25.1B | $16.3B | $32.7B | $18.8B |
| Supplier notes receivable | ($11.0M) | ($3.0M) | ($292.0M) | ($150.0M) |
| Other | ($1.0M) | ($4.0M) | — | — |
| Net cash provided/(used) by investing activities | $3.6B | $5.7B | ($5.9B) | ($3.9B) |
| New borrowings | $35.0M | $24.0M | $138.0M | $98.0M |
| Debt repayments | ($8.4B) | ($7.0B) | ($721.0M) | ($677.0M) |
| Employee taxes on certain share-based payment arrangements | ($32.0M) | ($31.0M) | ($28.0M) | ($18.0M) |
| Dividends paid on mandatory convertible preferred stock | ($172.0M) | ($86.0M) | ($244.0M) | ($158.0M) |
| Other | $32.0M | $15.0M | $43.0M | $30.0M |
| Net cash used by financing activities | ($8.5B) | ($7.0B) | ($812.0M) | ($725.0M) |
| Effect of exchange rate changes on cash and cash equivalents | $2.0M | $1.0M | $39.0M | $34.0M |
| Net decrease in cash & cash equivalents, including restricted | ($3.7B) | ($1.5B) | ($6.9B) | ($6.0B) |
| Cash & cash equivalents, including restricted, at beginning of year | $11.7B | $11.7B | $13.8B | $13.8B |
| Cash & cash equivalents, including restricted, at end of period | $8.0B | $10.2B | $6.9B | $7.8B |
| Less restricted cash & cash equivalents, included in Investments | $727.0M | $727.0M | $709.0M | $709.0M |
| Cash and cash equivalents at end of period | $7.2B | $9.4B | $6.2B | $7.1B |
Boeing Co score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.